Associate Professor Jayesh Desai
Research & Education Lead, Sarcoma
Medical Oncologist, Peter MacCallum Cancer Centre and The Royal Melbourne Hospital
View alliance profile
Associate Professor Jayesh Desai practices as a Medical Oncologist at the Royal Melbourne Hospital and the Peter MacCallum Cancer Centre in Melbourne. Associate Professor Desai also serves as an Associate Director for Cancer Trials Australia (CTA) and chairs the CTA Phase I Drug Development Group and is Chair of the Australasian Sarcoma Study Group.
Associate Professor Desai completed his Medical Oncology training in Melbourne in 2002, before spending three years as a Translational Research Fellow at the Dana-Farber Cancer Institute/Harvard Medical School in Boston, USA. His clinical and research interests focus on rationally developing new anti-cancer therapeutics and exploring predictive markers of response to these agents.
Associate Professor Desai has been Principal Investigator on more than a dozen first-in-human Phase 1 oncology trials, from small academically-focused groups and biotechs to large pharmaceutical company-sponsored trials. He has been closely involved in the development of Bionomic's Vascular Disrupting Agent, BNC105, as a Principal Investigator for that compound's first-in-human trial.
In 2018, Associate Professor Desai was appointed VCCC Research & Education Lead – sarcoma. In this role he is working to map opportunities across the alliance to develop expert networks, deliver strategic educational programming, improve sharing of data for research, and implement multi-partner clinical trials to speed up the translation of new research into routine clinical practice.